Description
An antineoplastic agent; inhibits DNA replication and cell proliferation and induces cell cycle arrest in the G1/S phase; inhibits proliferation of NCI H460 human lung cancer cells in vitro (IC50 = 0.56 mM); reduces RNR activity by 75% when used at a concentration of 5 mM via degradation of its active site tyrosyl radical; reduces leukocyte adhesion and extravasation in a humanized mouse model of SCD via NO production and a cGMP-dependent pathway; inhibits HIV-1 viral replication in PBMCs (IC90 = 0.4 mM),
Formal name: N-hydroxy-urea
Synonyms: NCI C04831|NSC 32065
Molecular weight: 76.1
CAS: 127-07-1
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Research Area|Cancer|Cell Cycle|G1||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS